Drugs Information Online
Drugs and diseases reference index

Drugs and diseases reference index
Search
EN

Drugs A-Z List

Diseases & Conditions A-Z List

Herbs & Supplements

Medical Dictionary

Full Article

Popular Drugs

Popular Diseases & Conditions

Drugs reference index «cisplatin»

cisplatin


cisplatin

Generic Name: cisplatin (sis PLA tin)Brand names: Platinol (Restricted Access), Platinol-AQ

What is cisplatin?

Cisplatin is an antineoplastic medication. Cisplatin interferes with the growth of cancer cells and slows their growth and spread in the body.

Cisplatin is used to treat various types of cancer including metastatic testicular tumors, metastatic ovarian tumors, and advanced bladder cancer.

Cisplatin may also be used for purposes other than those listed in this medication guide.

What is the most important information I should know about cisplatin?

Cisplatin should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.

Serious side effects have been reported with the use of cisplatin including: allergic reactions (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); kidney damage (little or no urine production, blood in the urine); hearing loss or ringing in the ears; decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection); severe nausea, vomiting, diarrhea, and loss of appetite; and others. Talk to your doctor about the possible side effects from treatment with cisplatin.

Who should not use cisplatin?

Do not use cisplatin without first talking to your doctor if you have
  • kidney disease;
  • poor bone marrow function;

  • hearing impairment; or

  • an allergy to platinum or platinum-containing products.

The use of cisplatin may be dangerous if you have any of the conditions listed above.

Cisplatin is in the FDA pregnancy category D. This means that cisplatin is known to be harmful to an unborn baby. Do not use cisplatin without first talking to your doctor if you are pregnant. Discuss with your doctor the appropriate use of birth control during treatment with cisplatin if necessary. Cisplatin passes into breast milk and may harm a nursing baby. Breast-feeding should be avoided during treatment with cisplatin.

How should I use cisplatin?

Cisplatin should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.

Your doctor will determine the correct amount and frequency of treatment with cisplatin depending upon the type of cancer being treated and other factors. Talk to your doctor if you have any questions or concerns regarding the treatment schedule.

Adequate hydration is important during treatment with cisplatin. Your doctor may prescribe the administration of intravenous fluids and/or recommend additional fluid intake by mouth during treatment.

Your doctor will probably want you to have regularly scheduled blood tests and other medical evaluations during treatment with cisplatin to monitor progress and side effects.

Your healthcare provider will store cisplatin as directed by the manufacturer. If you are storing cisplatin at home, follow the directions provided by your healthcare provider.

What happens if I miss a dose?

Contact your doctor if you miss a dose of cisplatin.

What happens if I overdose?

If for any reason an overdose of cisplatin is suspected, seek emergency medical attention or contact your healthcare provider immediately.

Symptoms of a cisplatin overdose tend to be similar to side effects caused by the medication, although often more severe.

What should I avoid while using cisplatin?

There are no restrictions on food, beverages, or activity while using cisplatin unless otherwise directed by your doctor.

Cisplatin side effects

If you experience all of the following serious side effects from cisplatin, contact your doctor immediately:

  • an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);

  • kidney damage (little or no urine production, blood in the urine);

  • hearing loss or ringing in the ears;

  • decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection);

  • severe nausea, vomiting, diarrhea, and loss of appetite;

  • heart and circulation problems;

  • gout or increased uric acid in the blood;

  • numbness or tingling;

  • blurred vision, altered color perception, blindness, and other visual problems;

  • liver damage (abdominal pain, yellowing of the skin or eyes); or

  • hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Cisplatin Dosing Information

Usual Adult Dose for Testicular Cancer:

20 mg/m2 intravenously once a day for 5 days per cycle (in combination with other antineoplastic drugs)

Usual Adult Dose for Ovarian Cancer:

75 to 100 mg/m2 intravenously once every 4 weeks (in combination with cyclophosphamide for the treatment of metastatic ovarian cancer).Alternatively, 100 mg/m2 intravenously once every 4 weeks may be administered (as a single agent for the treatment of metastatic ovarian cancer).If the ovarian cancer remains confined to the peritoneal cavity, the following regimens may be used:60 to 90 mg/m2 in 2 liters of 0.9% sodium chloride solution or lactated Ringer's injection intraperitoneally once.Alternatively, 90 to 270 mg/m2 in 2 liters of 0.9% sodium chloride solution or lactated Ringer's injection intraperitoneally once may be administered (to be given with intravenous sodium thiosulfate to reduce the risk of nephrotoxicity associated with this relatively high dose).

Usual Adult Dose for Bladder Cancer:

50 to 70 mg/m2 intravenously once every 3 to 4 weeks (as a single agent for the treatment of advanced bladder cancer in patients WITHOUT history of extensive X-radiation or chemotherapy).Alternatively, 50 mg/m2 intravenously over 6 to 8 hours every 4 weeks may be administered (as a single agent for the treatment of advanced bladder cancer in patients WITH history of extensive X-radiation or chemotherapy)

Usual Adult Dose for Neuroblastoma:

60 to 100 mg/m2 once every 3 to 4 weeks

Usual Adult Dose for Osteogenic Sarcoma:

60 to 100 mg/m2 once every 3 to 4 weeks

Usual Adult Dose for Brain/Intracranial Tumor:

60 mg/m2 once a day for two consecutive days every 3 to 4 weeks

Usual Adult Dose for Bone Marrow Transplantation:

Continuous infusion: High Dose: 55 mg/m2/day for 72 hours (Total Dose = 165 mg/m2)

Usual Adult Dose for Blood Cell Transplantation:

Continuous infusion: High Dose: 55 mg/m2/day for 72 hours (Total Dose = 165 mg/m2)

Usual Adult Dose for Non-Small Cell Lung Cancer:

60 to 100 mg/m2 intravenously on day one every 21 days (in combination with other antineoplastic drugs)

Usual Adult Dose for Cervical Cancer:

(In combination with radiation therapy)40 mg/m2 IV weeklyMaximum dose: 70 mg/weekCisplatin is given 4 hours before radiation therapy on weeks 1 through 6(In combination with paclitaxel)75 mg/m2 IV on day 2The cycle is repeated every 21 days.(In combination with other chemotherapeutic agents as a part of the BIP regimen)50 mg/m2 IV on day 2The cycle is repeated every 21 days.(In combination with other chemotherapeutic agents as a part of various regimens)50 to 200 mg/m2 IV on day 1

What other drugs will affect cisplatin?

Before using cisplatin, tell your doctor if you are using any of the following medicines to control seizures:

  • carbamazepine (Tegretol, Carbatrol, Epitol);

  • phenytoin (Dilantin);

  • gabapentin (Neurontin);

  • tiagabine (Gabitril);

  • valproic acid (Depakene) or divalproex sodium (Depakote);

  • lamotrigine (Lamictal);

  • felbamate (Felbatol);

  • levetiracetam (Keppra);

  • primidone (Mysoline);

  • zonisamide (Zonegran);

  • topiramate (Topamax);

  • oxcarbazepine (Trileptal);

  • a barbiturate such as mephobarbital (Mebaral) or pentobarbital (Nembutal); or

  • a benzodiazepine such as lorazepam (Ativan), diazepam (Diastat, Valium), clonazepam (Klonopin), or clorazepate (Tranxene).

Cisplatin may decrease the effects of medicines used to control seizures and a dosage adjustment may be required.

Drugs other than those listed here may also interact with cisplatin. Talk to your doctor and pharmacist before taking any other prescription or over-the-counter medicines, including herbal products, during treatment with cisplatin.

Where can I get more information?

  • Your healthcare provider may have additional information about cisplatin that you may read.
  • Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
  • Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2006 Cerner Multum, Inc. Version: 2.02. Revision Date: 4/12/2009 4:36:21 PM.
  • cisplatin Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information
  • Cisplatin Professional Patient Advice (Wolters Kluwer)
  • Cisplatin MedFacts Consumer Leaflet (Wolters Kluwer)

See Also...

Comment «cisplatin»